As shown in Table 3, the study conducted by Sfakianoudis et al. [21] showed an increase in serum AMH level after treatment with PRP for the cohorts of poor ovarian response, premature ovarian insufficiency, perimenopause, and menopause, respectively. This evidence concerns the gene AMH and Premature ovarian insufficiency.